IFNG and glioblastoma: Based on the outcomes, EphA2 CAR-T cell therapy greatly improved the survival rate of the GBM humanized mouse model, and the antitumor efficacy of EphA2 CAR-T cells was connected to CXCR-1 / 2 overexpression and appropriate IFN-γ production.